|
WT1 Expression in Patients with MDS Treated with ATG an*
|
5R21CA119599-02
|
$268,352
|
$134,176
|
DEEG, H
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Whole Body Hyperthermia and Anti-Tumor Immune Response
|
5R01CA071599-09
|
$280,252
|
$28,025
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Visualizing Tumors and Mechanisms of Therapy in Vivo
|
5R01CA080006-08
|
$234,613
|
$23,461
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
2R01CA056533-15A1
|
$416,980
|
$416,980
|
Schneider, Robert
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
VEGI-192 As An Anticancer Therapeutic Agent
|
5R01CA113875-02
|
$228,476
|
$57,119
|
LI, LUYUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
|
5R01CA079218-08
|
$328,425
|
$16,421
|
GILL, PARKASH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
$94,960
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
$1,134
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
$4,791
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$13,622
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use p105(sr) to study p50 homodimer in skin tumor/cancer
|
5R01CA104912-04
|
$203,349
|
$50,837
|
LIN, LI
|
MEDSTAR RESEARCH INSTITUTE
|
|
Unusual Regulation of the NF-kappaB/IKK Pathway by Ras
|
5R01CA073756-09
|
$249,182
|
$24,918
|
BALDWIN JR, ALBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Ultraviolet-Induced Signal Trasduction
|
5R01CA077646-08
|
$236,453
|
$23,645
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S2
|
$3,773,055
|
$264,114
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S3
|
$78,561
|
$5,499
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Tyrosine Protein Kinases and Lymphocyte Activation
|
2R01CA037372-24
|
$244,523
|
$80,693
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Tumor Necrosis Factor-alpha Signaling in Breast Cancer
|
3R01CA071727-07S1
|
$42,672
|
$42,672
|
Basu, Alakananda
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
Tumor Necrosis Factor-alpha Signaling in Breast Cancer
|
5R01CA071727-07
|
$223,842
|
$223,842
|
Basu, Alakananda
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
Tumor Gangliosides and TNF Synergize for T Cell Death
|
5R01CA111917-03
|
$257,865
|
$257,865
|
TANNENBAUM, CHARLES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S2
|
$4,309,306
|
$129,279
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S3
|
$57,159
|
$1,715
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
2R01CA087952-06A1
|
$234,840
|
$117,420
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
To Understand/Augment OX40-mediated Tumor Immunotherapy
|
5R01CA102577-05
|
$300,210
|
$300,210
|
WEINBERG, ANDREW
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
TNF Modulation of Mammary Proliferation
|
5R01CA077656-09
|
$346,227
|
$346,227
|
IP, MARGOT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis
|
5R01CA102431-04
|
$254,537
|
$254,537
|
VERMA, AJIT
|
UNIVERSITY OF WISCONSIN MADISON
|
|
TIP-B1 Protects Against TNF-Induced Apoptosis: Mechanism
|
5R01CA093594-04
|
$221,675
|
$221,675
|
BERLETH, ERICA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
$2,328
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
$849
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-32
|
$3,716,537
|
$37,165
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
|
5R01CA084040-08
|
$303,208
|
$75,802
|
FRANZOSO, GUIDO
|
UNIVERSITY OF CHICAGO
|
|
The molecular mechanism of TNF-induced necrotic cell death
|
Z01 BC 010783
|
$255,891
|
$255,891
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
2P01CA023766-29
|
$2,005,952
|
$100,298
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
3P01CA023766-28S1
|
$872,075
|
$43,604
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Targeted antigen receptor treatment of cancer
|
5P01CA033049-24
|
$2,150,453
|
$215,045
|
HOUGHTON, ALAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
T cell alternative p38 activation pathway
|
Z01 BC 010774
|
$417,993
|
$208,996
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Syk and associated proteins in breast cancer
|
1R01CA115465-01A2
|
$253,507
|
$63,377
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-09
|
$292,811
|
$73,203
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
STAT3 Acetylation and Deacetylation in Metastasis
|
5R01CA102128-03
|
$280,899
|
$14,045
|
CHIN, Y
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
|
Stanford University Cancer Center
|
1P30CA124435-01
|
$1,500,000
|
$15,000
|
WEISSMAN, IRVING
|
STANFORD UNIVERSITY
|
|
SPORE in Lymphoma
|
3P50CA096888-05S1
|
$1,150,000
|
$287,500
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Breast Cancer
|
3P50CA058207-12S2
|
$270,000
|
$13,500
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
SPORE in Breast Cancer
|
5P50CA058207-13
|
$2,359,341
|
$117,967
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Sphingolipids in Cancer Therapy and Angiogenesis
|
3P01CA097132-05S1
|
$52,844
|
$5,284
|
HANNUN, YUSUF
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Sphingolipids in Cancer Therapy and Angiogenesis
|
5P01CA097132-05
|
$1,071,665
|
$107,167
|
HANNUN, YUSUF
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Specialized Cancer Center Support Grant
|
2P30CA023100-23
|
$3,966,000
|
$118,980
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S1
|
$115,875
|
$3,476
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S2
|
$92,700
|
$2,781
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
SIGNAL TRANSDUCTION AND CELL DEATH REGULATION
|
5P01CA069381-12
|
$1,703,076
|
$340,615
|
REED, JOHN
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Signal integration of the death receptor pathways
|
5R01CA083817-07
|
$218,579
|
$109,290
|
YIN, XIAO-MING
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
SELECTIVE THERAPY FOR COLON CARCINOMA
|
7R01CA032613-25
|
$309,836
|
$77,459
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
Total relevant funding to Tumor Necrosis Factor for this search: $27,837,071
|